An international team of scientists recently completed a "massive initiative" to evaluate the ability of available microarray platforms and accompanying algorithms to discover copy number variation in genes implicated in diseases.
Led by researchers at Uppsala University in Sweden and the Hospital for Sick Children in Toronto, the team tested 11 different microarray platforms and found that current methods of analysis only detect a portion of the CNVs in the genome in any given experiment.